Project Details
Description
A phase II trial of irreversible electroporation for the treatment of unresectable locally advanced pancreatic cancer.
Acronym | CHEMOFIRE-2 |
---|---|
Status | Active |
Effective start/end date | 01/05/2019 → 30/04/2024 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Prizes
-
ISEBTT early career investigator award for research of exceptional quality
Flak, Rasmus Virenfeldt (Recipient), 6 Sept 2019
Prize: Conference prizes
File